X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (218) 218
female (193) 193
oncology (158) 158
adult (124) 124
index medicus (121) 121
breast neoplasms - genetics (116) 116
middle aged (114) 114
mutation (104) 104
breast cancer (98) 98
risk factors (80) 80
genes, brca1 (71) 71
genetic predisposition to disease (67) 67
aged (66) 66
article (62) 62
women (62) 62
cancer (61) 61
ovarian neoplasms - genetics (54) 54
genes, brca2 (51) 51
genetic testing (49) 49
risk (47) 47
male (46) 46
genetic aspects (45) 45
brca1 (42) 42
germ-line mutation (41) 41
ovarian-cancer (39) 39
breast neoplasms - prevention & control (38) 38
risk assessment (36) 36
brca1 protein - genetics (35) 35
breast-cancer (35) 35
health aspects (35) 35
ovarian cancer (33) 33
gene mutations (31) 31
genetic counseling (31) 31
heterozygote (31) 31
brca2 protein - genetics (30) 30
breast neoplasms - pathology (28) 28
breast neoplasms - diagnosis (27) 27
breast neoplasms - epidemiology (27) 27
genetics (27) 27
medicine, general & internal (26) 26
adolescent (25) 25
diagnosis (24) 24
prognosis (23) 23
skin and connective tissue diseases (23) 23
genes (22) 22
prevention (22) 22
tumors (22) 22
brca2 (21) 21
genetic screening (21) 21
research (21) 21
young adult (21) 21
breast (20) 20
case-control studies (20) 20
mutation carriers (20) 20
pedigree (20) 20
families (19) 19
genetics & heredity (19) 19
aged, 80 and over (18) 18
carriers (18) 18
germline mutations (18) 18
mutations (18) 18
prospective studies (18) 18
surgery (18) 18
tamoxifen (18) 18
age factors (17) 17
analysis (17) 17
child (17) 17
clinical medicine (17) 17
expression (17) 17
medical and health sciences (17) 17
medicin och hälsovetenskap (17) 17
medicine & public health (17) 17
neoplasm staging (17) 17
ovariectomy (17) 17
public, environmental & occupational health (17) 17
dna mutational analysis (16) 16
endocrine system diseases (16) 16
li-fraumeni syndrome (16) 16
li-fraumeni syndrome - genetics (16) 16
medical research (16) 16
prevalence (16) 16
breast neoplasms - drug therapy (15) 15
cancer and oncology (15) 15
cancer och onkologi (15) 15
carcinoma (15) 15
follow-up studies (15) 15
gene (15) 15
incidence (15) 15
klinisk medicin (15) 15
mammography (15) 15
neoplasms - genetics (15) 15
ovarian neoplasms - prevention & control (15) 15
retrospective studies (15) 15
age of onset (14) 14
chemotherapy (14) 14
mastectomy (14) 14
predictive value of tests (14) 14
susceptibility (14) 14
age (13) 13
breast neoplasms - therapy (13) 13
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Genetics in Medicine, ISSN 1098-3600, 10/2019
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 12/2016, Volume 34, Issue 34, pp. 4187 - 4188
Journal Article
Transactions of the American Clinical and Climatological Association, ISSN 0065-7778, 2016, Volume 127, pp. 127 - 139
Journal Article
British Journal of Cancer, ISSN 0007-0920, 07/2018, Volume 119, Issue 2, pp. 141 - 152
Testing for germline BRCA1/2 mutations has an established predictive role in breast cancer risk assessment. More recently, studies have also identified BRCA1/2... 
PLATINUM-BASED THERAPY | POLY(ADP-RIBOSE) POLYMERASE | DNA-REPAIR DEFECT | RIBOSE POLYMERASE INHIBITORS | ONCOLOGY | HOMOLOGOUS RECOMBINATION DEFICIENCY | MUTATION CARRIERS | OVARIAN-CANCER | PHASE-I | SOMATIC MUTATIONS | PATHOLOGICAL COMPLETE RESPONSE | Humans | Ovarian Neoplasms - pathology | Piperazines - therapeutic use | Poly(ADP-ribose) Polymerase Inhibitors - adverse effects | DNA Repair - genetics | Germ-Line Mutation - genetics | Breast Neoplasms - drug therapy | Piperazines - adverse effects | Poly(ADP-ribose) Polymerase Inhibitors - therapeutic use | Ovarian Neoplasms - genetics | BRCA1 Protein - genetics | Phthalazines - therapeutic use | Breast Neoplasms - genetics | Poly(ADP-ribose) Polymerases - genetics | Breast Neoplasms - pathology | Progression-Free Survival | Female | Ovarian Neoplasms - drug therapy | BRCA2 Protein - genetics | Phthalazines - adverse effects | Salts | Ovarian carcinoma | Homologous recombination | Poly(ADP-ribose) | Homology | Taxane | ADP | Cancer therapies | DNA repair | Subgroups | Ovarian cancer | Homologous recombination repair | Pathways | Ribose | Platinum | Risk assessment | Repair | Deoxyribonucleic acid--DNA | BRCA1 protein | Health risks | Poly(ADP-ribose) polymerase | Breast cancer | Patients | Polymerase | Chemotherapy | Inhibitors | Anthracycline | Breast | Mutation | Health risk assessment | Cancer | Review
Journal Article
Journal of the National Cancer Institute, ISSN 0027-8874, 09/2018, Volume 110, Issue 9, pp. 925 - 926
Journal Article
Cancer, ISSN 0008-543X, 10/2019
Journal Article
Journal Article
Lancet, The, ISSN 0140-6736, 2010, Volume 376, Issue 9737, pp. 235 - 244
Journal Article